tiprankstipranks
Iofina PLC (GB:IOF)
LSE:IOF

Iofina plc (IOF) AI Stock Analysis

15 Followers

Top Page

GB:IOF

Iofina plc

(LSE:IOF)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
29.00 p
▲(17.17% Upside)
Action:UpgradedDate:12/07/25
Iofina plc's overall stock score is driven by its strong financial stability and strategic corporate developments. While technical indicators suggest caution due to overbought conditions, the company's valuation and growth prospects remain attractive.
Positive Factors
Low Leverage / Strong Balance Sheet
A debt-to-equity of 0.09 gives Iofina durable financial flexibility: lowers interest burden, preserves capacity for cyclical downturns, and supports capital allocation for plant expansion or product development without near-term refinancing risk, strengthening longer-term resilience.
Negative Factors
Margin erosion
Material declines in gross and net margins indicate structural pressure from higher costs or weaker realized iodine/product pricing. Persisting margin compression reduces retained earnings, limits reinvestment capacity, and undermines long-term profitability unless cost structure or pricing power improves.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Balance Sheet
A debt-to-equity of 0.09 gives Iofina durable financial flexibility: lowers interest burden, preserves capacity for cyclical downturns, and supports capital allocation for plant expansion or product development without near-term refinancing risk, strengthening longer-term resilience.
Read all positive factors

Iofina plc (IOF) vs. iShares MSCI United Kingdom ETF (EWC)

Iofina plc Business Overview & Revenue Model

Company Description
Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemicals, disinfectants, electronic specialty ga...
How the Company Makes Money
Iofina generates revenue primarily through the sale of high-purity iodine and iodine derivatives, which are sold to various sectors including pharmaceuticals, agricultural chemicals, and industrial applications. The company employs a unique extrac...

Iofina plc Financial Statement Overview

Summary
Iofina plc demonstrates a stable financial position with low leverage and strong cash flow generation. However, declining profitability margins and return on equity indicate challenges in maintaining growth and efficiency.
Income Statement
65
Positive
Balance Sheet
75
Positive
Cash Flow
70
Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue57.65M54.47M50.04M42.20M39.04M29.69M
Gross Profit14.36M13.24M15.65M15.83M10.73M8.40M
EBITDA8.37M7.65M10.64M12.07M7.13M4.61M
Net Income4.82M2.92M6.56M7.87M9.19M1.28M
Balance Sheet
Total Assets70.23M63.78M60.52M52.71M44.45M39.83M
Cash, Cash Equivalents and Short-Term Investments6.42M6.86M6.52M5.93M5.26M4.38M
Total Debt7.47M4.26M5.84M7.20M8.68M12.62M
Total Liabilities19.91M15.99M15.77M14.73M14.48M19.18M
Stockholders Equity50.32M47.79M44.75M37.97M29.96M20.66M
Cash Flow
Free Cash Flow-1.70M2.02M2.34M2.46M6.41M1.33M
Operating Cash Flow8.37M11.53M8.57M5.55M7.89M3.78M
Investing Cash Flow-9.94M-9.34M-6.10M-3.07M-1.47M-2.43M
Financing Cash Flow2.19M-1.85M-1.88M-1.81M-4.64M-6.58M

Iofina plc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price24.75
Price Trends
50DMA
25.02
Positive
100DMA
24.56
Positive
200DMA
24.48
Positive
Market Momentum
MACD
-0.13
Negative
RSI
62.57
Neutral
STOCH
73.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IOF, the sentiment is Positive. The current price of 24.75 is above the 20-day moving average (MA) of 24.27, below the 50-day MA of 25.02, and above the 200-day MA of 24.48, indicating a bullish trend. The MACD of -0.13 indicates Negative momentum. The RSI at 62.57 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IOF.

Iofina plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
£49.31M6.349.82%8.48%29.33%
66
Neutral
£4.02B60.706.17%3.45%2.36%-13.99%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
£3.22B-46.91-5.87%3.54%-4.60%-126.46%
60
Neutral
£117.36M32.053.64%4.08%1.12%-0.70%
58
Neutral
£866.19M-28.06-6.85%1.34%-11.78%-92.61%
51
Neutral
£63.30M-1.25-7.26%-4.41%2.29%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IOF
Iofina plc
25.70
5.20
25.37%
GB:CRDA
Croda International
2,877.00
364.95
14.53%
GB:ELM
Elementis
152.40
40.15
35.76%
GB:JMAT
Johnson Matthey
1,922.00
807.61
72.47%
GB:SYNT
Synthomer
38.70
-46.10
-54.36%
GB:TET
Treatt plc
198.80
-111.66
-35.97%

Iofina plc Corporate Events

Business Operations and StrategyFinancial Disclosures
Iofina Posts Record Iodine Output and Beats 2025 Earnings Expectations
Positive
Jan 13, 2026
Iofina reported a record 743.2 metric tonnes of crystalline iodine production in 2025, up 17.2% year-on-year, driven by strong output from its eight IOsorb® plants in Oklahoma and a robust sales cycle in the second half of the year. The compa...
Business Operations and StrategyExecutive/Board Changes
Iofina Appoints Tim Hughes as Non-Executive Director to Bolster Iodine Expansion
Positive
Dec 12, 2025
Iofina plc has announced the appointment of Tim Hughes as a Non-Executive Director, effective from January 1, 2026. Hughes brings extensive experience from the specialty chemical industry, having held significant roles at Synthomer plc and Chemtur...
Business Operations and StrategyProduct-Related Announcements
Iofina Partners with Western Midstream for New IOsorb® Plant in Permian Basin
Positive
Dec 5, 2025
Iofina plc has announced an agreement with Western Midstream Partners to develop a new IOsorb® plant in the Permian Basin, which will utilize the company’s WET IOsorb® technology to extract iodine from produced water. This new faci...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025